Product Information
GSK3326595 is a potent and selective inhibitor of CDK4/6. It has been shown to inhibit the proliferation of cancer cells, including breast, prostate, lung and pancreatic cancers. GSK3326595 inhibits the activity of CDK4 and CDK6 by binding to the ATP-binding site on these kinases. This inhibition leads to decreased levels of phosphorylation of RB1 at Ser807 and Ser811, which in turn activates p53 protein. The activation of p53 protein leads to induction of apoptosis in cancer cells.
Chemical properties
Technical inquiry about: 3D-RPC39222 GSK3326595
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
